StockData

RCM Technologies vs TrueBlue

RCMT and TBI side by side, both in personnel supply services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RCMT and TBI compare

TrueBlue is the larger company, worth 1.6 times as much as RCM Technologies ($370M against $226M).

RCM Technologies grew revenue faster over the last twelve months (11.2% versus 10.2% for TrueBlue).

RCM Technologies keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with −3.3% at TrueBlue.

RCM Technologies scores higher on the StockData Score (13 against 6 for TrueBlue), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRCMTTBI
Size and price
Market cap$226M$370M
Share price$31.73$12.16
Change, 1 year67.9%147%
Change, 5 years331%−53.7%
Beta (5Y)1.451.95
Employees2503,500
StockData Score
Total score13 (better)6
Valuation score22
Growth score11
Performance score4 (better)0
Health score6 (better)3
Dividend score00
Valuation
P/E13.7×–
P/S0.7×0.2× (better)
P/B4.6×1.5× (better)
EV/EBITDA7.8×–
P/FCF9.9×–
PEG6.02–
FCF yield10.1% (better)−18.2%
Fair value$32.48$14.25
Margin of safety2.3%14.6% (better)
Growth
Revenue growth (TTM)11.2% (better)10.2%
Revenue growth, 5Y average16.3% (better)−2.6%
Net income growth (TTM)25.9%–
EPS growth (TTM)31.3%–
Profitability
Gross margin26.9% (better)21.2%
Operating margin7.7% (better)−2.9%
Net margin5.1% (better)−3.3%
FCF margin6.8% (better)−4.0%
Return on equity39.5% (better)−20.2%
Return on invested capital51.2% (better)−12.4%
Financial health
Debt / equity0.000.32 (better)
Current ratio1.922.28 (better)
Altman Z-score5.35 (better)4.03
Piotroski F-score8 (better)4
Dividends and buybacks
Buyback yield3.9%–
Shareholder yield3.9% (better)0.00%
Ownership
Held by institutions41.1%85.1%
Held by insiders33.3%7.7%
Insider net buying, 12 months−$12.6M−$35.6K (better)
Short interest, % of float5.0%1.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.